Page last updated: 2024-10-28

guanfacine and Diabetic Angiopathies

guanfacine has been researched along with Diabetic Angiopathies in 2 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.

Research Excerpts

ExcerptRelevanceReference
"Efficacy of guanfacine was studied in 20 hypertensive patients and 20 patients with diabetes mellitus and hypertension in a 12-month follow-up."5.06Long-term clinical experience with guanfacine. ( Brimichová, G; Dzúrik, R; Fetkovská, N; Sebeková, K, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fetkovská, N1
Brimichová, G1
Sebeková, K1
Dzúrik, R1
Dvorák, I1
Podrouzková, B1
Kocourková, J1
Kubesová, H1
Spác, J1
Nĕmcová, H1
Blaha, M1

Trials

2 trials available for guanfacine and Diabetic Angiopathies

ArticleYear
Long-term clinical experience with guanfacine.
    Cor et vasa, 1987, Volume: 29, Issue:4 Suppl 1

    Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diabetic Angiopathies; Follow-Up

1987
Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Cor et vasa, 1987, Volume: 29, Issue:4 Suppl 1

    Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabet

1987